Linzagolix versus leuprorelin in Japanese women with uterine leiomyomas: a phase 3, randomized, active-controlled, non-inferiority trial.
- DOI
- 10.1093/humrep/deag106
- Published
- 2026 Sep 1
- Container
- Human reproduction (Oxford, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/humrep/deag106,
title = {Linzagolix versus leuprorelin in Japanese women with uterine leiomyomas: a phase 3, randomized, active-controlled, non-inferiority trial.},
author = {Osuga Y and Harada T and Takahashi H and Kawai A and Shimamura F and KLH2301 Investigators},
year = {2026},
journal = {Human reproduction (Oxford, England)},
doi = {10.1093/humrep/deag106},
url = {https://doi.org/10.1093/humrep/deag106}
}RIS
TY - JOUR TI - Linzagolix versus leuprorelin in Japanese women with uterine leiomyomas: a phase 3, randomized, active-controlled, non-inferiority trial. AU - Osuga Y AU - Harada T AU - Takahashi H AU - Kawai A AU - Shimamura F AU - KLH2301 Investigators PY - 2026 JO - Human reproduction (Oxford, England) DO - 10.1093/humrep/deag106 UR - https://doi.org/10.1093/humrep/deag106 ER -
APA
Y, O., T, H., H, T., A, K., F, S., & Investigators, K. (2026). Linzagolix versus leuprorelin in Japanese women with uterine leiomyomas: a phase 3, randomized, active-controlled, non-inferiority trial.. Human reproduction (Oxford, England). https://doi.org/10.1093/humrep/deag106
Source records
- pubmed · retrieved 2026-09-26T18:37:46.338Z